Long-term Interventional Follow-up Study up to 4 Years of Age of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial and Comparison With an Untreated Cohort of Children With Prader-Willi Syndrome
Latest Information Update: 01 Apr 2026
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Adverse reactions
- Acronyms OTBB3-FU
Most Recent Events
- 01 Apr 2026 New trial record